Cerevel Therapeutics
CERE
$41.99
Share price
-0.26%
Change (1 day)
44.44%
Change (1 year)
Categories
Cerevel Therapeutics (CERE) - Net assets
Net assets on the balance sheet as of December 2023 : $0.67 B
According to Cerevel Therapeutics's latest financial reports the company has $0.67 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Cerevel Therapeutics - Net assets on balance sheet (from 2020 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.67 B | 29.26% |
| 2022-12-31 | $0.52 B | -9.93% |
| 2021-12-31 | $0.57 B | 50.51% |
| 2020-12-31 | $0.38 B | 394.1% |
| 2019-12-31 | $77.82 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Archer Daniels Midland (ADM)
ADM | $24.46 B | 3,531.20% | 🇺🇸 USA |
 Campbell Soup CPB | $3.85 B | 471.58% | 🇺🇸 USA |
 Dow DOW | $19.10 B | 2,736.09% | 🇺🇸 USA |
 Dupont De Nemours DD | $24.72 B | 3,569.79% | 🇺🇸 USA |